Page 139 - Pagetit

NEUROSCIENCE OF PSYCHOACTIVE SUBSTANCE USE AND DEPENDENCE

McKenna DJ, Peroutka SJ (1990) Neurochemistry and neurotoxicity of 3,4-
methylenedioxymethamphetamine, MDMA (“ecstasy”). Journal of
Neurochemistry, 54:14–22.
Maldonado R, Rodriguez de Fonseca F (2002) Cannabinoid addiction: behavioural
models and neural correlates. Journal of Neuroscience, 22:3326–3331.
Malin DH (2001) Nicotine dependence studies with a laboratory model.
Pharmacology, Biochemistry and Behavior, 70:551–559.
Mansour A, Watson SJ (1993) Anatomical distribution of opioid receptors in
mammalian: an overview. In: Hertz A, ed. Opioids I. Berlin, Springer-Verlag:79–
105.
Mansour A et al. (1995) Opioid-receptor mRNA expression in the rat CNS:
anatomical and functional implications. Trends in Neuroscience, 18:22–29.
Marona-Lewicka D et al. (1996) Reinforcing effects of certain serotonin-releasing
amphetamine derivates. Pharmacology, Biochemistry and Behavior, 53:99–105.
3
Martin BR et al. (1976) H-delta-9-tetrahydrocannabinol tissue and subcellular
distribution in the central nervous system and tissue distribution in peripheral
organs of tolerant and nontolerant dogs. Journal of Pharmacology and
Experimental Therapeutics, 196:128–144.
Mascaró BI et al. (1991) MDMA “extasis”: revisión y puesta Al día. [MDMA
“ecstasy”: revision and updates]. Revista Española de Drogodependencias, 16:91–
101.
Mason BJ (2001) Treatment of alcohol-dependent outpatients with acamprosate:
a clinical review. Journal of Clinical Psychiatry, 62(Suppl.)20:S42–S48.
Matsuda LA et al. (1990) Structure of a cannabinoid receptor and functional
expression of the cloned cDNA. Nature, 346:561–564.
Mechoulam R et al. (1995) Identification of an endogenous 2-monoglyceride,
present in canine gut, that binds to cannabinoid receptors. Biochemical Pharma-
cology, 50:83–90.
Meisch RA (2001) Oral drug self-administration: an overview of laboratory animal
studies. Alcohol, 24:117–128.
Miyazawa A et al. (1999) Nicotinic acetylcholine receptor at 4.6 A resolution:
transverse tunnels in the channel wall. Journal of Molecular Biology, 288:765–
786.
Molina-Holgado F, Lledo A, Guaza C (1997) Anandamide suppresses nitric oxide
and TNF-alpha responses to Theiler’s virus or endotoxin in astrocytes.
Neuroreport, 8:1929–1933.
Montoya AG et al. (2002) Long-term neuropsychiatric consequences of “ecstasy”
(MDMA): a review. Harvard Review of Psychiatry, 10:212–220.
Morgan MJ (2000) Ecstasy (MDMA): a review of its possible persistent
psychological effects. Psychopharmacology, 152:230–248.
Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a
peripheral receptor for cannabinoids. Nature, 365:61–65.
Munzar P et al. (2001) High rates of midazolam self-administration in squirrel
monkeys. Behavioural Pharmacology, 12:257–265.

118

Chapter_4 118 19.1.2004, 11:44